Members of the genus Brucella are categorized as biothreat agents and pose a hazard for both humans and animals. Current identification methods rely on biochemical tests that may require up to 7 days for results. We sequenced the 16S rRNA genes of 65 Brucella strains along with 17 related strains likely to present a differential diagnostic challenge. All Brucella 16S rRNA gene sequences were determined to be identical and were clearly different from the 17 related strains, suggesting that 16S rRNA gene sequencing is a reliable tool for rapid genus-level identification of Brucella spp. and their differentiation from closely related organisms.
Brucella spp., the causative agents of brucellosis, are pathogenic to a variety of domesticated and wild animals. The genus Brucella is comprised of gram-negative, facultative, intracellular pathogens (1) . Phenotypic characteristics, antigenic variation, and prevalence of infection in different animal hosts have resulted in the initial recognition of six species: B. abortus (cattle), B. melitensis (goats/sheep), B. suis (swine), B. canis (dogs), B. ovis (rams), and B. neotomae (desert rats) (13, 27) . Recently two Brucella strains from different marine mammals have been reported (7, 11, 22) , and the names B. pinnipediae (seal/otter) and B. cetaceae (porpoise/whale) have been proposed (12) . DNA hybridization analyses indicate a high level of homology among the brucellae, suggesting that the genus Brucella may comprise only one species with several biovars (40) .
Brucellosis impacts public health and agricultural economies worldwide because of its high infectivity rate (13) . Brucella spp. have also long been considered a potential biological weapon (20) , and currently, with the renewed threat of biological warfare and agricultural terrorism, B. melitensis, B. suis, and B. abortus are listed as category B biothreat agents by the Centers for Disease Control and Prevention Strategic Planning Group (34) .
Infections in humans generally result from (i) transmission via the gastrointestinal route by the consumption of unpasteurized diary products (18, 32) and contaminated meat (25) , (ii) airborne transmission in animal husbandry by inhaling dust contaminated by aborted tissues (23) , and (iii) transmission caused by laboratory-associated exposure to aerosols (26) . In the event of a bioterror attack, the preferred method of dissemination would most likely be via aerosol (3, 20, 34) .
Because of the limited availability of animal vaccines, cost of animal inoculations, a lack of vaccines for human use (13, 37) , and its low infectious dose for humans, human brucellosis is endemic in many parts of the world, including the Mediterranean region, Latin America, Asia, and Africa. The reported incidence varies from Ͻ0.01 to Ͼ200 per 100,000 population (13) . Human brucellosis is rare in the United States, with approximately 100 human cases reported per year, mostly caused by consumption of unpasteurized diary products and, to a lesser degree, occupational exposure (10, 38) .
The rapidity with which a laboratory diagnosis can be obtained is an important component of every outbreak investigation, because knowledge about the causative agent plays a pivotal role in implementing appropriate public health decisions in a timely manner (21, 34) . At present, diagnosis of human brucellosis depends primarily on isolation of Brucella spp. from blood (43), followed by performing a set of bacteriological tests that allows for reliable identification to the subspecies (biotype) level but that requires up to 7 days for completion (1, 42) . Another diagnostic option is the use of serologic assays; however, the specificity of these tests is inconsistent because of cross-reactivity with bacteria closely related to the genus Brucella (29) .
Extensive efforts have been expended on the development of molecular diagnostic assays based on amplification of different genomic targets by the PCR for the identification of Brucella spp., as recently reviewed by Bricker (6) . Although these molecular approaches appeared to be faster and more sensitive than traditional bacteriological tests, they are not considered to be confirmatory tests due to limited specificity (8, 9, 14) . Recently a multiplex system has been developed that is sensitive for Brucella spp. and is able to differentiate between B. melitensis and B. abortus (33) . However, discrepant results were observed with some B. abortus isolates. So far, none of these assays has been accepted for common use in diagnostic laboratories.
In collaboration with the Association of Public Health Laboratories, the Centers for Disease Control and Prevention Laboratory Response Network has developed standard algorithms based on traditional bacteriological tests (1) for the identification of Brucella spp. by Laboratory Response Network laboratories. Our current efforts are aimed at developing and validating more rapid methods that will allow confirmatory identification of Brucella spp. from cultures and, subsequently, directly in clinical specimen samples.
We chose to evaluate 16S rRNA gene sequencing to determine its utility for confirmatory identification of Brucella spp. The advantage of this method is that results can be obtained within 1 day as compared to 7 days by traditional microbiological testing. Previous work on other bacteria has indicated that differences in 16S rRNA gene sequences may be useful for subtyping or for the differentiation of virulent subtypes from nonvirulent subtypes (30, 36) . Low variability in the 16S rRNA locus has been noted as an impediment in using 16S rRNA gene sequencing to discriminate at the species level (41); recent studies of other biothreat select agents have indicated that even subtle differences in the 16S rRNA gene sequence may be used for differentiating and identifying closely related species, which are often cross-reactive in biochemical identification systems commonly used in diagnostic laboratories (19, 35) . In this study, we have primarily focused on the applicability of 16S rRNA gene sequencing as a rapid confirmatory identification tool and consequently have sequenced the near-full-length 16S rRNA genes of a reference set of Brucella isolates that represent the species commonly encountered in animal and human infections. In addition, we sequenced 17 closely related diagnostically challenging strains.
MATERIALS AND METHODS
Bacterial strains. In this study, 65 Brucella strains (representing six species) from a collection of over 600 were selected to represent temporal, geographic, and source diversity (Table 1) . A panel of 17 related strains likely to present a differential diagnostic challenge was also selected for comparison ( Table 2 ). All strains were stored at Ϫ70°C in defibrinated rabbit blood until testing. Identification of all strains was carried out by standard microbiological procedures as described previously (42) .
Amplification of 16S rRNA genes. Bacteria were grown by plating one loop (1 l) of stock cell suspension on Trypticase soy agar with 5% defibrinated sheep blood agar (BBL Microbiology Systems, Cockeysville, Md.) and incubating the bacteria aerobically for 1 to 2 days at 37°C with 5% CO 2 . To yield a DNA template, a single colony was suspended in 200 l of 10 mM Tris (pH 8.0) in a 1.5-ml Millipore 0.22-m-pore-diameter filter unit (Millipore, Bedford, Mass.) and heated at 95°C for 30 min. The filter unit was then centrifuged at 6,000 ϫ g for 5 min to recover the filtrate containing the DNA template. Each final PCR (100 l) contained 5 U of Expand DNA polymerase (Roche, Indianapolis, Ind.), 2 l of DNA template, 10 mM Tris-HCl (pH 8.0), 50 mM KCl, 1.5 mM MgCl 2 , 200 M (each) dATP, dCTP, dGTP, and dTTP, and 0.4 M each of eubacterial primers F8 (5Ј AGTTTGATCCTGGCTCAG 3Ј) and R1492 (5Ј ACCTTGTTA CGACTT 3Ј) (17) . Reaction mixtures were first incubated for 5 min at 95°C. Then 35 cycles were performed as follows: 15 s at 94°C, 15 s at 50°C, and 1 min 30 s at 72°C. Reaction mixtures were then incubated at 72°C for an additional 5 min. PCR products were purified with a Qiaquick PCR purification kit (Qiagen, Valencia, Calif.).
16S rRNA gene sequencing. Sequencing primers were chosen from a panel of eubacterial primers: F8, R1492 (described above), F357 (5Ј TACGGGAGGCA GCAG 3Ј), R357 (5Ј CTGCTGCCTCCCGTA 3Ј), F530 (5Ј CAGCAGCCGCG GTAATAC 3Ј), R530 (5Ј GTATTACCGCGGCTGCTG 3Ј), F790 (5Ј ATTAG ATACCCTGGTAG 3Ј), R790 (5Ј CTACCAGGGTATCTAAT 3Ј), F1068 (5Ј GTCGTCAGCTCGTGTCGTGAG 3Ј), F1083 (5Ј CGTGACATGTTGGGTT AAGTC 3Ј), F981 (5Ј CCCGCAACGAGCGCAACCC 3Ј), and R981 (5Ј GGG TTGCGCTCGTTGCGGG 3Ј) (17, 28, 35) . For non-Brucella strains sequenced for comparison, four additional eubacterial primers were used: R1333 (5Ј CTA GCGATTCCGACTTCATGC 3Ј), R180 (5Ј TCTCTCAAGACGTATGCGG TA 3Ј), R591 (5Ј CATCCTGCTTAAGTAACCGTC 3Ј), and F1127 (5Ј ATTA GTTGCCATCATTCAGTT 3Ј). Sequencing was performed with an Applied Biosystems (ABI, Foster City, Calif.) BigDye terminator cycle sequencing kit (version 2.0, 1.1, or 1.0) per the manufacturer's instructions, with the exception of using 6 l of BigDye instead of 8 l. Sequencing products were purified by using Centri-Sep spin columns (Princeton Separations, Adelphia, N.J.), and these sequencing products were resolved with an ABI model 3100 automated DNA sequencing system (ABI).
Computer analysis of 16S rRNA gene sequences. (i) Evaluation of the 16S rRNA gene sequences of Brucella spp. The 16S rRNA gene sequencing of the amplified products obtained with PCR primers F8 and R1492 generated 1,412-bp-long sequences that closely matched the size of previously published Brucella 16S rRNA gene sequences. The length of these sequences was close to the full length of the gene, which is 1,485 bp (5, 7, 16) , and thus allowed direct comparisons.
The software package used for all data analysis was the Accelrys, Inc. (San Diego, Calif.), GCG Wisconsin package, version 10.2. The raw trace files from the ABI 3100 sequencer were visually examined, aligned, and edited (SEQ-MERGE).
We compared the Brucella sequences by using DISTANCES to determine the level of similarity among them. The sequences generated in this study were compared with previously published Brucella spp. sequences by using BESTFIT to determine levels of similarity between sequences.
(ii) Comparisons of 16S rRNA gene sequences of Brucella spp. to sequences of closely related strains. The eubacterial primers F8 and R1492 were also used for the panel of related strains likely to present a differential diagnostic challenge. The 16S rRNA gene sequences from the amplification products that resulted from F8 and R1492 varied in length (1,377 to 1,491 bp). For the Agrobacterium, Ochrobactrum anthropi, Oligella urethralis, and Vibrio cholerae strains, the sequences were organized into sets by genus (Table 2 ) and aligned (PILEUP). A core segment of 1.4 to 1.5 kb was selected for each that was common to all the sequences in a given set by trimming sequences at the 5Ј and 3Ј ends. The level of similarity of the sequences in a set was then determined by using Jukes-Cantor correction (DISTANCES). The sequences within the Agrobacterium set matched each other 100%, as did the sequences within the O. anthropi and V. cholerae sets ( Table 2 ). The most divergent sequences within the O. urethralis set matched at 99.9% (Table 2) . A representative sequence from each set, as well as the 16S rRNA gene sequences from Escherichia coli O157:H7, Bartonella henselae, Afipia broomeae, and Afipia felis, were then compared to the Brucella consensus sequence to determine the level of similarity by BESTFIT (Table 3) .
Nucleotide sequence accession number. A total of 82 16S rRNA gene sequences were determined in this study (Tables 1 and 2 
RESULTS
Near-full-length 1,412-bp nucleotide sequences of the 16S rRNA genes from 65 Brucella strains (Table 1) comprising six Brucella spp. were generated. Upon alignment and comparison, all 16S rRNA gene sequences were determined to be identical. This result yielded a Brucella consensus sequence that was used for all comparisons.
A BLAST search (10 October 2003) on GenBank indicated that there were only 17 Brucella 16S rRNA gene sequences (from 10 strains) near 1.4 kb available in this public database (2) . Eleven of these gene sequences were a 100% match to our Brucella consensus sequence. Six of these 11 sequences were from B. melitensis strain 16 M and B. suis strain 1330, for which full genome sequences were published in 2002 (15, 31) . Both strains have two chromosomes, and each strain has three copies of the 16S rRNA gene with two copies on chromosome I and one copy on chromosome II (15, 31) . A BLAST analysis (8 October 2003) of both genome sequences on The Institute for Genomic Research website (http://tigrblast.tigr.org/cmr -BLAST/) (2) revealed that all three copies from each strain were a 100% match to our Brucella 16S rRNA gene consensus sequence. Two additional 16S rRNA sequences that were a 100% match to our Brucella consensus sequence are those of Hills, unpublished data), which differed from the consensus sequence by 1 to 6 bp. Three of these four sequences had Ns in the sequences, indicating an inability to identify bases. B. abortus strain 11/19 was not available for resequencing: however, this strain is the same as U.S. strain 19 (E. Moreno, personal communication). We sequenced the 16S rRNA genes from B. abortus U.S. strain 19, B. melitensis strain ATCC 23456, B. neotomae strain ATCC 23459, and B. canis strain ATCC 23365. All four sequences were a 100% match to the Brucella consensus sequence.
Comparisons with the panel of 17 related strains likely to present a differential diagnostic challenge indicated that the sequence most similar to the Brucella consensus sequence was that from an O. anthropi strain at 98.8% similarity (Table 3) , which is consistent with the relationship seen in previous phylogenetic studies (39) . There is a difference of 16 bp, as well as a deletion and an insertion, which easily differentiates the Brucella consensus sequence from this sequence. The other 16S rRNA gene sequences from this panel of strains had even more pronounced differences (Table 3) .
DISCUSSION
Current confirmatory identification of Brucella isolates relies upon a set of traditional microbiological tests that requires up to 7 days for completion. At the same time, safety concerns have limited the wide application of automated identification systems, which could potentially shorten the time from collection of an unknown specimen to obtaining the laboratory diagnosis. ). Consequently, because Brucella spp. typically require several days of incubation before attaining a level of growth sufficient for the interpretation of various phenotypic tests (1), a more rapid approach for identification is needed, especially for a timely response to a potential biothreat event.
The critical advantage of 16S rRNA gene sequencing is based on its ability to be used for identification of unknown isolates. By using the broad-range eubacterial primers, as demonstrated in this study, a 16S rRNA gene sequence can be readily obtained, allowing for rapid confirmatory identification of an unknown isolate as a Brucella species by simple comparison to the consensus sequence. Confirmatory identification can then serve as a guide to continue all subsequent work with biosafety level 3 practices, while the rapidity with which it is obtained may be the critical factor needed for quickly implementing control and preventative measures in an emergency biothreat situation (6, 34) . The PCR tests previously proposed limit the laboratorian to either positively identifying gene regions associated with a Brucella species or ruling out Brucella spp., which would then require subsequent diagnostic tests to identify the etiologic agent. Sequencing the 16S rRNA gene enables querying a database such as GenBank to yield an alternative identification without the need for any additional laboratory work. Consequently, given that the clinical presentation of brucellosis can resemble diseases caused by other select agents, this global diagnostic approach will be invaluable in a potential biothreat setting. We have added to the robustness of this approach by submitting to GenBank 82 high-quality 16S rRNA gene sequences from Brucella spp. and close relatives, which allows for a more accurate comparison of sequences.
One additional advantage of using 16S rRNA gene sequencing is that this method may be able to identify the causative organism from clinical specimens of patients who have received antimicrobial agents prior to the collection of specimens, as has been demonstrated recently during the 2001 bioterrorism-associated anthrax investigation (35) . Because antimicrobial and other supportive treatment will not differ regardless of the Brucella species causing the illness (4), detection of the Brucella-specific 16S rRNA gene sequence will be advantageous for timely treatment of patients even without species identification.
Our result of 100% identity of the 16S rRNA gene sequence among the large number of Brucella strains tested is consistent with previous studies using a limited number of strains (5, 7) and could also be used to support proposals that Brucella may be a monospecific genus, based on the DNA hybridization studies that indicate a Ͼ77% level of homogeneity for the Brucella spp. (40) . Vizcaíno et al. observed that there was some variability in the 16S rRNA locus, but not enough to separate the Brucella species (41) . Similarly, there are some Brucella 16S rRNA gene sequences in GenBank that differ from the consensus sequence. We resequenced all but one of these discrepant GenBank submissions. Each was a 100% match to the Brucella consensus sequence. We do not believe the differences in the sequences from the original GenBank entries represent microheterogeneity in the 16S rRNA genes of these Brucella strains. Rather, these discrepant sequences were submitted from 1989 to 1995 before the advent of automated sequencing technologies with higher fidelity. This is supported by the presence of unresolved bases in some of these discrepant sequences.
A comparison of the Brucella 16S rRNA consensus sequence with those of close relatives indicates that sequencing of the first 500 bp is sufficient to differentiate them. The closest This work demonstrates that 16S rRNA gene sequencing can provide rapid confirmatory identification of an isolate as a Brucella species, allowing prompt and appropriate public health responses to be implemented. This approach will be of even greater value if shown to be effective when used directly on clinical specimens; studies are under way in our laboratory to evaluate its sensitivity and specificity on clinical specimens of patients with culture-confirmed brucellosis.
